Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by Medscape Podcasts. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Medscape Podcasts or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Sep 12 2025 This Week in Cardiology

31:05
 
Share
 

Manage episode 505987947 series 2794872
Content provided by Medscape Podcasts. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Medscape Podcasts or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

More from ESC including: Valvular HD guidelines, a new drug class for HTN, myosin inhibition in HCM, vericiguat, and digoxin are the topic discussed by John Mandrola, MD.

This podcast is intended for healthcare professionals only.

To read a partial transcript or to comment, visit:

https://www.medscape.com/twic

I New European Valvular Heart Disease Guidelines

II New Drug for Resistant HTN

III HCM News at ESC

IV Vericiguat at ESC

V More on Digoxin

You may also like:

The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington

Questions or feedback, please contact [email protected]

  continue reading

376 episodes

Artwork
iconShare
 
Manage episode 505987947 series 2794872
Content provided by Medscape Podcasts. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Medscape Podcasts or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

More from ESC including: Valvular HD guidelines, a new drug class for HTN, myosin inhibition in HCM, vericiguat, and digoxin are the topic discussed by John Mandrola, MD.

This podcast is intended for healthcare professionals only.

To read a partial transcript or to comment, visit:

https://www.medscape.com/twic

I New European Valvular Heart Disease Guidelines

II New Drug for Resistant HTN

III HCM News at ESC

IV Vericiguat at ESC

V More on Digoxin

You may also like:

The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington

Questions or feedback, please contact [email protected]

  continue reading

376 episodes

Усі епізоди

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play